A Study of TL-925 for the Treatment of Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:December 1, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Allergic ConjunctivitisLast Updated:December 1, 2023Recruiting
Condition(s):Allergic ConjunctivitisLast Updated:May 6, 2023Recruiting
Condition(s):Conjunctivitis, Allergic; Conjunctivitis, VernalLast Updated:October 26, 2022Recruiting
Condition(s):Allergic ConjunctivitisLast Updated:March 5, 2024Not yet recruiting
Condition(s):Allergic ConjunctivitisLast Updated:January 16, 2024Recruiting
Condition(s):Dry Eye Syndrome; Infectious Keratoconjunctivitis; Mucous Membrane Pemphigoid; Allergic ConjunctivitisLast Updated:November 28, 2022Recruiting
Condition(s):AllergyLast Updated:August 24, 2022Recruiting
Condition(s):Atopic DermatitisLast Updated:September 6, 2023Recruiting
Condition(s):Allergic Rhinoconjunctivitis; Birch Pollen AllergyLast Updated:December 29, 2022Not yet recruiting
Condition(s):AsthmaLast Updated:February 6, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.